4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-000924
President and CEO sold 34,950 shares at an average $5.86 ($204,878)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AUERBACH ALAN H President and CEO | 2026-01-06 | Sale 10b5-1 | −16,938 | $5.84 | $98,986 | 7,163,963 | D |
| AUERBACH ALAN H President and CEO | 2026-01-07 | Sale 10b5-1 | −18,012 | $5.88 | $105,893 | 7,145,951 | D |
| Open-market sales · 34,950 sh · avg $5.86 · $204,878 | |||||||
Loading xslF345X05/rdgdoc.xml…